These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16723602)

  • 1. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of Acinetobacter baumannii-infected rats.
    Dahyot C; Marchand S; Pessini GL; Pariat C; Debaene B; Couet W; Mimoz O
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2265-7. PubMed ID: 16723602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats.
    Marchand S; Dahyot C; Lamarche I; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2356-61. PubMed ID: 15917533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of experimental hypovolemia on imipenem muscle distribution in rats assessed by microdialysis.
    Marchand S; Dahyot C; Lamarche I; Plan E; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4974-9. PubMed ID: 16304160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdialysis study of imipenem distribution in the intraperitoneal fluid of rats with or without experimental peritonitis.
    Lefeuvre S; Marchand S; Lamarche I; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2006 Jan; 50(1):34-7. PubMed ID: 16377663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
    Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
    J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility.
    Lesho E; Wortmann G; Moran K; Craft D
    Clin Infect Dis; 2005 Sep; 41(5):758-9. PubMed ID: 16080102
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
    Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
    J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia.
    Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J
    Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis study of imipenem distribution in the peritoneal fluid of rats with experimental acute pancreatitis.
    Lefeuvre S; Marchand S; Pariat C; Lamarche I; Couet W
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1516-8. PubMed ID: 18195055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia.
    Pichardo C; Pachón-Ibañez ME; Docobo-Perez F; López-Rojas R; Jiménez-Mejías ME; Garcia-Curiel A; Pachon J
    Eur J Clin Microbiol Infect Dis; 2010 May; 29(5):527-31. PubMed ID: 20182760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
    Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia.
    Rodríguez-Hernández MJ; Pachón J; Pichardo C; Cuberos L; Ibáñez-Martínez J; García-Curiel A; Caballero FJ; Moreno I; Jiménez-Mejías ME
    J Antimicrob Chemother; 2000 Apr; 45(4):493-501. PubMed ID: 10747827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
    Dizbay M; Tunccan OG; Sezer BE; Hizel K
    Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
    Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
    J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of gatifloxacin penetration into skeletal muscle and lung by microdialysis in rats.
    Tasso L; Bettoni CC; Oliveira LK; Dalla Costa T
    Int J Pharm; 2008 Jun; 358(1-2):96-101. PubMed ID: 18400426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.